According to the latest market report published by Credence Research, Inc. “Cholera vaccines Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global cholera vaccines market was valued at US$ 51.3 Mn in 2016, and is expected to reach US$ 234.5 Mn by 2025, expanding at a CAGR of 15.8% from 2017 to 2025.
The Cholera Vaccines Market Research Report Forecast 2017-2025 is an important source of insightful data for market strategists. It presents the Cholera Vaccines industry overview with growth analysis and past & futuristic cost, income, demand and supply data (as relevant). The research analysts present a detailed representation of the value chain and its distributor analysis. This Cholera Vaccines market study gives complete data which improves the understanding. [Continue reading…]
According to World Health Organization (WHO), there are roughly 1.3 to 4.0 million cholera cases, and 21,000 to 143,000 deaths worldwide each year due to cholera. The burden of cholera remains high globally, particularly in developing countries in Asia and Africa. Cholera prevention and treatment protocols are well established; government initiatives in immunization program is prime factor driving the market growth of cholera vaccines globally. For the purpose of study, the cholera vaccines market is segmented on the basis of product type such as Dukoral, Shanchol, Vaxchora and others; it is estimated that Vaxchora would grow significantly during forecast period because Vaxchora is the only vaccine available in the United States for protection against cholera and the only single dose vaccine for cholera currently licensed anywhere in the world. Centers for Disease Control and Prevention’s (CDC) and Advisory Committee on Immunization Practices (ACIP) recommended the use of Vaxchora in 18 to 64 years of age adults.
Browse here for full report: https://www.credenceresearch.com/report/cholera-vaccines-market
Analysis of trends in the global Cholera Vaccines industry and interest for Cholera Vaccines in various regions, including Asia-Pacific, Europe, and North America
Market size and value of Cholera Vaccines used for commercial Cholera Vaccines from 2011 to 2017 and forecast for eight years up until 2025
The qualitative study of drivers and limitations of Cholera Vaccines market
- Astellas Pharma, Inc.
- Valneva SE
Reasons to Buy
Gain up to date report and axnalysis about the global Cholera Vaccines market
Recognize key regions and countries that describe potential growth possibilities for the Cholera Vaccines market
Facilitate decision making by understanding the opportunities presented by the Cholera Vaccines market
Gain information about major players in the Cholera Vaccines market
Get Sample Copy: https://www.credenceresearch.com/sample-request/58514
Research methodology and delivery time
Credence Research has conducted in depth secondary research to arrive at key insights. Data collected from key public industry sources and publications have been scanned and analyzed impartially to present a clear picture of the industry. All recent developments which impact the sector dynamics have been captured and used to support the research hypothesis.
The report is available as the single-site single-user license. The delivery time for the electronic version of the report is 3 business days as each copy undergoes thorough quality check and is updated with the most recent information available.
Download Free PDF Request for Customization: https://www.credenceresearch.com/request-for-customization/58514
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US